Clinical Trial Update: Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 clinical trial evaluating salvage strategy options for post-injectable cabotegravir in HIV prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• APRETUDE (CABOTEGRAVIR)

Snippet

Sponsor: University of Witwatersrand, South Africa | Conditions: HIV Prevention | Phase 4 | Status: ACTIVE_NOT_RECRUITING